Royal Bank of Canada’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-700
| Closed | -$1K | – | 6578 |
|
|
2024
Q1 | $1K | Buy |
700
+108
| +18% | +$154 | ﹤0.01% | 6293 |
|
|
2023
Q4 | $0 | Sell |
592
-18,433
| -97% | – | ﹤0.01% | 6508 |
|
|
2023
Q3 | $15K | Buy |
19,025
+18,866
| +11,865% | +$14.9K | ﹤0.01% | 5774 |
|
|
2023
Q2 | $0 | Buy |
159
+130
| +448% | – | ﹤0.01% | 6733 |
|
|
2023
Q1 | $0 | Hold |
29
| – | – | ﹤0.01% | 6620 |
|
|
2022
Q4 | $0 | Sell |
29
-58
| -67% | – | ﹤0.01% | 6690 |
|
|
2022
Q3 | $0 | Hold |
87
| – | – | ﹤0.01% | 6899 |
|
|
2022
Q2 | $0 | Hold |
87
| – | – | ﹤0.01% | 6848 |
|
|
2022
Q1 | $0 | Buy |
87
+3
| +4% | – | ﹤0.01% | 7206 |
|
|
2021
Q4 | $0 | Buy |
+84
| New | – | ﹤0.01% | 7073 |
|
|
2021
Q2 | – | Sell |
-3,000
| Closed | -$16K | – | 6922 |
|
|
2021
Q1 | $16K | Hold |
3,000
| – | – | ﹤0.01% | 6051 |
|
|
2020
Q4 | $16K | Buy |
+3,000
| New | +$16K | ﹤0.01% | 5602 |
|
|
2020
Q3 | – | Sell |
-1,000
| Closed | -$10K | – | 6069 |
|
|
2020
Q2 | $10K | Sell |
1,000
-946
| -49% | -$9.46K | ﹤0.01% | 5343 |
|
|
2020
Q1 | $6K | Sell |
1,946
-1,108
| -36% | -$3.42K | ﹤0.01% | 5462 |
|
|
2019
Q4 | $3K | Buy |
3,054
+1,054
| +53% | +$1.04K | ﹤0.01% | 5857 |
|
|
2019
Q3 | $3K | Hold |
2,000
| – | – | ﹤0.01% | 5516 |
|
|
2019
Q2 | $8K | Sell |
2,000
-196
| -9% | -$784 | ﹤0.01% | 5229 |
|
|
2019
Q1 | $10K | Buy |
2,196
+196
| +10% | +$893 | ﹤0.01% | 5099 |
|
|
2018
Q4 | $12K | Buy |
2,000
+1,000
| +100% | +$6K | ﹤0.01% | 5029 |
|
|
2018
Q3 | $14K | Hold |
1,000
| – | – | ﹤0.01% | 5233 |
|
|
2018
Q2 | $12K | Sell |
1,000
-16
| -2% | -$192 | ﹤0.01% | 5173 |
|
|
2018
Q1 | $11K | Buy |
1,016
+951
| +1,463% | +$10.3K | ﹤0.01% | 5054 |
|
|
2017
Q4 | $0 | Buy |
+65
| New | – | ﹤0.01% | 5731 |
|